View this email in your browser.
MAR
14
IN THIS ISSUE
  NEWS
  Alaska Scientists Continue Researching Seabird Death Mystery
  NEWS
  Majority of California Adults have Prediabetes or Diabetes
  PRODUCT
  Cleanroom High-Speed Roll-Up Doors
  NEWS
  Soap Bubbles for Treating Stenosed Blood Vessels
  NEWS
  Functional Heart Muscle Regenerated in Decellularized Human Hearts

Advancing Cancer Research with SOMAscan®

Somalogic

Download this bundle that covers challenges facing cancer researchers in proteomics and how new advances are furthering this promising technology.

LEARN MORE
 
FEATURED STORY

Breast Cancer Drug Combination Could Shrink Tumors in Days

Featured Story

A combination of breast cancer drugs administered before surgery could drastically shrink particular tumors within days - and potentially eliminate the need for chemotherapy in some patients, according to British researchers.


Share Facebook Twitter Google+ LinkedIn StumbleUpon

FULL STORY
 
 

2015 R&D 100 Awards & Technology Conference

Register Now

Learn new strategies for your research as you engage with the world's most successful innovators at the 2015 R&D 100 Awards & Technology Conference. Elevate your level of knowledge, expertise, and increase your productivity and successful outcomes.


REGISTER NOW
 
 
NEWS

Alaska Scientists Continue Researching Seabird Death Mystery

Thumbnail

Sarah Schoen, a wildlife biologist for the U.S. Geological Survey, and Rob Kaler, a biologist for the U.S. Fish and Wildlife Service, on Friday performed necropsies on common murres, part of an effort by dozens of scientists to explain the massive die-off of common murres that began one year ago.


FULL STORY
 
 
NEWS

Majority of California Adults have Prediabetes or Diabetes

Thumbnail

Nearly half of California adults, including one out of every three young adults, have either prediabetes - a precursor to type 2 diabetes - or undiagnosed diabetes, according to a study.


FULL STORY
 
 

Integrated Biosafety Solutions for the Modern Laboratory

The Baker Company

What Makes Your Laboratory Unique? Your people, your protocols, the work you do to change the world - and the instruments and equipment that help you to reach your goals. You shouldn't have to fit your workflows around standard equipment. Your Equipment should be adaptable to you, while operating within the safety, performance, and compliance parameters that your work requires. In short, your laboratory equipment should work the way you do.


READ THE WHITEPAPER
 
 
FOCUS ON:

Cleanroom High-Speed Roll-Up Doors

Thumbnail

Large format roll-up doors from Terra Universal are installed in positive- or negative-pressure cleanrooms when oversized objects or mobile carts and workstations need to be transferred in or out.


FULL STORY
 
 
NEWS

Soap Bubbles for Treating Stenosed Blood Vessels

Thumbnail

Liposomes are currently used as drug delivery vehicles but recognized by the immune system. Scientists from the universities of Basel and Fribourg have shown that special artificial liposomes do not elicit any reaction in human and porcine sera as well as pigs.


FULL STORY
 
 

Innovative Method for Detecting and Quantifying Aflatoxins Using General Equipment

Horizon Technologies

With the requirement to increase testing of agricultural and food products for the presence of aflatoxins, reliable and convenient testing methods that utilize readily available standard laboratory tools are in demand. For the general laboratory, newer technologies for aflatoxin analysis may be financially unattainable. This app note focuses on the innovative method developed to accurately test aflatoxins using general equipment.


READ THE WHITEPAPER
 
 
NEWS

Functional Heart Muscle Regenerated in Decellularized Human Hearts

Thumbnail

Researchers have taken some initial steps toward the creation of bioengineered human hearts using donor hearts stripped of components that would generate an immune response and cardiac muscle cells generated from induced pluripotent stem cells (iPSCs), which could come from a potential recipient.


FULL STORY
 
 
NEWS

FDA Expands Use of Pfizer Drug for Rare Form of Lung Cancer

Thumbnail

The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation.


FULL STORY
 
Bioscience Technology
Facebook Twitter
SUBSCRIBEUNSUBSCRIBEABOUT USADVERTISE
This email was sent by: Bioscience Technology
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129
We respect your right to privacy - click here to view our policy.

©2016 Bioscience Technology. All rights reserved.